Nanopore sequencing offers advantages in all areas of research. Our offering includes DNA sequencing, as well as RNA and gene expression analysis and future technology for analysing proteins.

Learn about applications
View all Applications
Resources Investors Careers News About Store Community Contact

Oxford Nanopore initiates legal proceedings against Pacific Biosciences

Fri 21st April 2017

On Friday 21st April 2017, Oxford Nanopore initiated its first legal proceedings in Europe against Pacific Biosciences* for infringement of EP1192453, which Oxford Nanopore has an exclusive right to commercialise under a license agreement with Harvard University.

This first suit was issued in the Patents Court of the High Court’s Chancery Division, UK.

Update 25th April: Oxford Nanopore has subsequently issued a second suit in Germany at the Mannheim Court.


*refers to Pacific Biosciences of California Inc and Pacific Biosciences Ltd (UK) in UK proceedings and Pacific Biosciences of California Inc in German proceedings.

Open a chat to talk to our sales team